Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.59 |
| ▸ | BID | P55957 | 3/20 | 0.57 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.57 |
| ▸ | PPARA | Q07869 | 3/20 | 0.57 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.57 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.57 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.57 |
| ▸ | PPARG | P37231 | 2/20 | 0.57 |
| ▸ | EP300 | Q09472 | 1/20 | 0.57 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.57 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.57 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.57 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.57 |
| ▸ | SLC16A3 | O15427 | 4/20 | 0.55 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.53 |
| ▸ | PLK1 | P53350 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL623528 | 1.00 | FOLH1 (0.59) | FOLH1BIDMCL1PPARABCL2L1 | |
| SCHEMBL5171335 | 1.00 | FOLH1 (0.59) | FOLH1BIDMCL1PPARABCL2L1 | |
| SCHEMBL586009 | 0.98 | BID (0.59) | FOLH1BIDMCL1PPARABCL2L1 | |
| SCHEMBL7920927 | 0.98 | BID (0.59) | FOLH1BIDMCL1PPARABCL2L1 | |
| SCHEMBL80184 | 0.98 | BID (0.59) | FOLH1BIDMCL1PPARABCL2L1 | |
| SCHEMBL5710015 | 0.98 | BID (0.59) | FOLH1BIDMCL1PPARABCL2L1 | |
| SCHEMBL8925891 | 0.98 | BID (0.59) | FOLH1BIDMCL1PPARABCL2L1 | |
| SCHEMBL1691931 | 0.98 | BID (0.59) | FOLH1BIDMCL1PPARABCL2L1 | |
| SCHEMBL467028 | 0.98 | BID (0.59) | FOLH1BIDMCL1PPARABCL2L1 | |
| SCHEMBL1562330 | 0.98 | BID (0.59) | FOLH1BIDMCL1PPARABCL2L1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119095818-A | Synthesis and purification method of cannabinic acid and acylated derivative thereof | 特雷斯科控股有限公司 | 2024-12-06 | — | — | CN | disclosed |
| EP-3733656-B1 | METHOD FOR SYNTHESIS OF LOBARIC ACID AND ANALOG THEREOF | KOREA INSTITUTE OF OCEAN SCIENCE AND TECH (KR) | 2023-05-10 | — | — | EP | disclosed |
| US-11434217-B2 | Method for synthesis of lobaric acid and analog thereof | KOREA INSTITUTE OF OCEAN SCIENCE AND TECHNOLOGY (KR) | 2022-09-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11434217-B2 | Method for synthesis of lobaric acid and analog thereof | PPP6C, PPP4C, PPP3CB | FOLH1 2056/4885BID 2376/4885MCL1 2261/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.